ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its' Clinical Training Expertise in MDMA-Assisted Therapy
ATMA Journey Centers Inc. ("ATMA"), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is pleased to announce its collaboration with Dr. Scott Shannon to prepare practitioners in training for the eagerly anticipated legalization of MDMA for MDMA-assisted therapy (MaT). Dr. Shannon will join Dr. Ben Sessa (psychiatrist and Bristol Imperial MDMA Study Academic), Mark Haden (Previous Executive Directors of MAPS Canada) and Ben Malcolm (Psychiatric Pharmacis...
Source: yahoo.com